Managing Preoperative Hemostasis in Patients with Inherited and Acquired Bleeding Disorders

This article gives an overview of the bleeding risks involved and therapeutic options to overcome them. [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: Seminars in Thrombosis and Hemostasis - Category: Hematology Authors: Tags: Review Article Source Type: research

Related Links:

Chem. Commun., 2020, Advance Article DOI: 10.1039/D0CC00513D, CommunicationZhongyan Wang, Chuanrui Ma, Yuna Shang, Lijun Yang, Jing Zhang, Cuihong Yang, Chunhua Ren, Jinjian Liu, Guanwei Fan, Jianfeng Liu An ingenious co-assembled nanosystem based on fenofibrate and ketoprofen peptide for the dual-targeted treatment of NAFLD by reducing hepatic lipid accumulation and inflammatory responses. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
Just wondering if anyone thinks that if this situation of "non-elective surgeries only" continues for a few months, what financial repercussions it may have on AMCs. I would imagine their overhead is more substantial than most smaller private practice groups, and how long are they willing to wait seeing no revenue (or a fraction of) before contemplating getting out? I am sure they'd ride it out if it was a matter of a few weeks/months, but what if this continues for 4/5/6+ months?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Anesthesiology Source Type: forums
Conditions:   Subarachnoid Hemorrhage;   Headache Intervention:   Drug: Regional anesthetic SPG block-bilateral Sponsor:   Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Anesthesia Interventions:   Procedure: Guiding Emergence From Anaesthesia With Tragus Pressure;   Procedure: Guiding Emergence From Anaesthesia Without Tragus Pressure Sponsor:   National University Hospital, Singapore Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Polyps Uterus Intervention:   Procedure: Polypectomy without anesthesia or analgo-sedation Sponsor:   Hopital Foch Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Cardiac Pacemaker Malfunction;   ICD Malfunction;   Cardiac Pacemaker Electrical Interference;   Anesthesia Complication;   Surgery--Complications Intervention:   Procedure: surgery or catheter based cardiac procedure (catheter ablation) Sponsors:   Klinikum-Fuerth;   Klinikum Nürnberg Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 1 April 2020Source: Annals of Medicine and SurgeryAuthor(s): Valiyeva Sayali, Romano Lucia, Maffione Francesco, Leopardi Marco, Giordano Aldo Victor, Lombardi Loreto, Schietroma Mario, Carlei Francesco, Giuliani Antonio
Source: Annals of Medicine and Surgery - Category: General Medicine Source Type: research
Authors: Francis T, Francis N, Lazarus JH, Okosieme OE Abstract Introduction: The thionamide antithyroid drugs, methimazole (MMI), its pro-drug derivative carbimazole (CMZ), and propylthiouracil (PTU) are the mainstay of treatment for hyperthyroidism in pregnancy. However, antithyroid drugs carry risks of adverse effects that can affect fetal and maternal well-being.Areas covered: This review provides an update on the safety of antithyroid drugs in pregnancy, focusing on the most serious concerns of severe liver disease and congenital anomalies.Expert opinion: PTU-induced liver disease is uncommon but can run a cat...
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research
Anticoagulant treatment is associated with better outcomes of portal-vein thrombosis (PVT) related to inflammatory bowel disease (IBD), according to new research.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Authors: Mujer MTP, Rai MP, Atti V, Dimaandal IL, Chan AS, Shrotriya S, Gundabolu K, Dhakal P Abstract Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagulation factor Xa inhibitors rivaroxaban, apixaban, edoxaban, and betrixaban. NOACs have several benefits over warfarin, including faster time to the achieve effect, rapid onset of action, fewer documented food and drug interactions, lack of need for routine INR monitoring, and improved patient satisfaction. Local hemostatic measures, supportive care, and withholding the next NOAC dose are usually sufficient to achie...
Source: Advances in Hematology - Category: Hematology Tags: Adv Hematol Source Type: research
More News: Anesthesia | Anesthesiology | Bleeding | Haemophilia | Hematology | Hemophilia | Liver | Liver Disease | Men | Thrombosis | Urology & Nephrology | von Willebrand Disease